The self-monitoring blood glucose (smbg) devices global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Self-Monitoring Blood Glucose (SMBG) Devices Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The self-monitoring blood glucose (smbg) devices market size has grown strongly in recent years. It will grow from $14.35 billion in 2023 to $15.71 billion in 2024 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to rise in prevalence of diabetes, increase in healthcare awareness, aging population, government initiatives and regulations, rise in healthcare spending.
The self-monitoring blood glucose (smbg) devices market size is expected to see strong growth in the next few years. It will grow to $22.15 billion in 2028 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to rising home healthcare, telehealth expansion, rise in disposable income, rising demand for remote monitoring, rise in e-commerce. Major trends in the forecast period include continuous glucose monitoring (cgm) integration, artificial intelligence (ai) and machine learning, wearable smbg devices, non-invasive monitoring, mobile apps and connectivity.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/self-monitoring-blood-glucose-smbg-devices-global-market-report
Scope Of Self-Monitoring Blood Glucose (SMBG) Devices Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Self-Monitoring Blood Glucose (SMBG) Devices Market Overview
Market Drivers –
The rising prevalence of diabetes is expected to propel the growth of the self-monitoring blood glucose device market going forward. Self-monitoring of blood glucose is a method in which person with diabetes use a glycemic reading gadget to measure their blood sugar (glucose meter) where they can change or monitor the effectiveness of their treatment (diet, exercise, insulin, antidiabetics) or see their physician based on the results of the test. For instance, according to the report published by the International Diabetes Federation in December 2021, diabetes affected 537 million adults (20–79 years old) in 2021, and it is predicted that the number is going to climb to 643 million people by 2030 and a total of 783 million by 2045. Therefore, the rising prevalence of diabetes is driving the growth of the self-monitoring blood glucose devices market.
Market Trends –
Technological advancement is a key trend gaining popularity in the self-monitoring blood glucose devices market. Major companies operating in the self-monitoring blood glucose devices market are focused on developing technologically advanced products to strengthen their position in the market. For instance, in September 2021, Know Labs Inc., a US-based company that manufactures glucose monitoring devices launched a new portable medical-grade glucose monitoring device named KnowU that utilizes Bio-RFID technology. This device is a non-invasive glucose monitoring machine that has a base that powers the device and displays readings and, a battery a powered monitor with Bio-RFID sensors that can be carried by the users to check sugar levels on the go. The KnowU is an affordable and convenient replacement for other expensive and painful blood glucose monitoring devices.
The self-monitoring blood glucose (smbg) devices market covered in this report is segmented –
1) By Product: Self-Monitoring Blood Glucose Meters, Continuous Glucose Monitors, Testing Strips, Lancets
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Sales, Diabetes Clinics & Centers
3) By Application: Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes
Get an inside scoop of the self-monitoring blood glucose (smbg) devices market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=6969&type=smp
Regional Insights –
North America was the largest region in the self-monitoring blood glucose (SMBG) devices market in 2023. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the self-monitoring blood glucose (smbg) devices market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Key Companies –
Major companies operating in the self-monitoring blood glucose (smbg) devices market include Abbott Laboratories, Bionime Corporation, B. Braun Melsungen AG, F. Hoffmann-La Roche Ltd, LifeScan Inc, PHC Holdings Corporation, Home Diagnostics Inc, Terumo Pharmaceutical Solutions, ARKRAY Inc, Ypsomed Holding AG, Dexcom Inc, Medtronic plc, Novo Nordisk A/S, Glysens Incorporated, Senseonics Holdings Inc., AgaMatrix Inc., All Medicus Co. Ltd., Ascensia Diabetes Care Holdings AG, Bayer AG, Becton Dickinson and Company, Bio-Rad Laboratories Inc., Bioptik Technology Inc., Cnoga Medical Ltd., ForaCare Inc., Glucovation Inc., Hainice Medical Inc., Infopia Co. Ltd., Insulet Corporation, Integrity Applications, Johnson & Johnson, Menarini Diagnostics, Nemaura Medical Inc., Nipro Corporation, Nova Biomedical Corporation, Omron Healthcare Inc., Optiscan Biomedical Corporation, OrSense Ltd., Pinnacle Technology Inc., Prodigy Diabetes Care LLC, PTS Diagnostics, TaiDoc Technology Corporation, Trividia Health Inc., WaveForm Technologies Inc.
Table of Contents
1. Executive Summary
2. Self-Monitoring Blood Glucose (SMBG) Devices Market Report Structure
3. Self-Monitoring Blood Glucose (SMBG) Devices Market Trends And Strategies
4. Self-Monitoring Blood Glucose (SMBG) Devices Market – Macro Economic Scenario
5. Self-Monitoring Blood Glucose (SMBG) Devices Market Size And Growth
…..
27. Self-Monitoring Blood Glucose (SMBG) Devices Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Explore Related Reports
https://goodprnews.com/healthcare-edi-market-outlook/
https://goodprnews.com/industrial-gas-regulators-market-share/
https://goodprnews.com/global-injection-pen-market-analysis/
https://goodprnews.com/joint-pain-injections-market-trends/
https://goodprnews.com/global-liquid-packaging-market-driver/
https://goodprnews.com/medical-electrodes-market-outlook/
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
